Is Elanco Animal Health Incorporated (ELAN) a Buy, Sell, or Hold?
NYSE : ELAN
Elanco Animal Health Incorporated — Institutional Ownership
$26.39 USD
-$0.07 (-0.26%)
- Volume
- 5.19M
- Average Volume
- 5.83M
- Market Capitalization
- $13.18B
- P/E Ratio
- -53.01
- Dividend Yield
- 0.00%
- Price Target
- $29.00
- Year High
- $27.72
- Year Low
- $13.39
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.16
Institutional Ownership Summary
Institutional Ownership %
2.78%
Investors Holding
171
change: -358 | last: 529
Increased Positions
65
change: -233 | last: 298
Reduced Positions
73
change: -76 | last: 149
New Positions
27
change: -68 | last: 95
Sold Positions
374
change: 307 | last: 67
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -77.5085 | last: 0.7751
Total Invested
340.87M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-14 | Dimensional Fund Advisors LP | 25.42M | 5.10% |
| 2026-05-14 | Dodge & Cox | 68.94M | 13.90% |
| 2026-05-13 | PRIMECAP MANAGEMENT CO/CA/ | 45.84M | 9.22% |
| 2026-04-29 | Vanguard Capital Management | 26.14M | 5.25% |
| 2026-04-09 | Dimensional Fund Advisors LP | 24.53M | 4.90% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2026-02-13 | Dodge & Cox | 79.08M | 15.90% |
| 2026-02-05 | FMR LLC | 52.2M | 10.50% |
| 2026-01-21 | Dimensional Fund Advisors LP | 25.08M | 5.00% |
| 2025-11-14 | T. Rowe Price Investment Management, Inc. | 31.55M | 6.40% |
| 2025-10-17 | BlackRock, Inc. | 44.02M | 8.90% |
| 2025-08-06 | FMR LLC | 64.88M | 13.10% |
| 2025-04-22 | BlackRock, Inc. | 22.02M | 4.40% |
| 2025-03-07 | FMR LLC | 49.54M | 10.00% |
| 2025-02-12 | FMR LLC | 40.23M | 8.10% |
| 2025-02-04 | BlackRock, Inc. | 24.87M | 5.00% |
| 2024-01-29 | (1) BlackRock, Inc. | 27.78M | 5.60% |
| 2022-07-08 | PAGE 2 OF 4 PAGES | 49.21M | 10.40% |
| 2022-02-14 | 52-0556948 | 34.67M | 7.30% |
| 2022-02-14 | Aristotle Capital Management, LLC | 29.21M | 6.17% |
| 2022-02-10 | EIN #00-0000000 | 11.6M | 2.50% |
| 2022-02-09 | The Vanguard Group - 23-1945930 | 40.8M | 8.62% |
| 2021-06-25 | ELANCO ANIMAL HEALTH INCORPORATED | 6.85M | 15.10% |
| 2021-06-25 | KNIGHT MERGER SUB, INC. | 6.85M | 15.10% |
| 2021-02-16 | 52-0556948 | 41.66M | 8.80% |
| 2021-02-12 | EIN #00-0000000 | 34.87M | 7.40% |
| 2021-02-12 | (. | 32.53M | 6.89% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 41.73M | 8.84% |
| 2021-02-05 | (1) BlackRock, Inc. | 28.79M | 6.10% |
| 2021-02-02 | Aristotle Capital Management, LLC | 25.2M | 5.34% |
| 2020-12-03 | 18,446,429* | 18.45M | 3.91% |
| 2020-12-03 | 18,446,429* | 18.45M | 3.91% |
| 2020-10-09 | (1) BlackRock, Inc. | 23.43M | 4.90% |
| 2020-10-07 | Sachem Head GP LLC | 11M | 2.30% |
| 2020-10-07 | Scott D. Ferguson | 27.84M | 5.90% |
| 2020-10-07 | Sachem Head Capital Management LP | 27.84M | 5.90% |
| 2020-10-07 | Uncas GP LLC | 27.84M | 5.90% |
| 2020-08-03 | (10) | 72.95M | 15.50% |
| 2020-08-03 | (10) | 72.95M | 15.50% |
| 2020-02-12 | PRIMECAP Management Company 95-3868081 | 30.6M | 8.20% |
| 2020-02-11 | The Vanguard Group - 23-1945930 | 34.08M | 9.13% |
| 2020-02-10 | 52-0556948 | 33.43M | 8.90% |
| 2020-02-07 | (1) BlackRock, Inc. | 19.45M | 5.20% |
| 2020-01-28 | Wellington Management Group LLP | 30.93M | 8.29% |
| 2020-01-28 | Wellington Management Company LLP | 27.71M | 7.43% |
| 2020-01-28 | Wellington Investment Advisors Holdings LLP | 30.93M | 8.29% |
| 2020-01-28 | Wellington Group Holdings LLP | 30.93M | 8.29% |
| 2019-05-07 | PRIMECAP Management Company 95-3868081 | 30.61M | 8.37% |
| 2019-04-10 | 52-0556948 | 38.68M | 10.50% |
| 2019-02-14 | Eli Lilly and Company | 293.29M | 80.20% |
ELAN Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $22.63 | 496.4M | $11.23B | $545M | $4.02B | $14.71B |
| 2024-12-31 | $12.11 | 494M | $5.98B | $468M | $4.32B | $9.84B |
| 2023-12-31 | $14.90 | 492.3M | $7.34B | $352M | $5.77B | $12.76B |
| 2022-12-31 | $12.22 | 488.3M | $5.97B | $345M | $5.84B | $11.46B |
| 2021-12-31 | $28.38 | 487.2M | $13.83B | $638M | $6.32B | $19.51B |
| 2020-12-31 | $30.67 | 441.4M | $13.54B | $495M | $6.13B | $19.17B |
| 2019-12-31 | $29.45 | 369M | $10.87B | $334M | $2.36B | $12.89B |
| 2018-12-31 | $31.53 | 313.7M | $9.89B | $474.8M | $2.47B | $11.89B |
| 2017-12-31 | $36.00 | 356.2M | $12.82B | $323.4M | -$ | $12.5B |
| 2016-12-31 | $36.00 | 356.2M | $12.82B | $258.8M | -$ | $12.56B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23.93 | 497.7M | $11.91B | $428M | $3.99B | $15.47B |
| 2025-12-31 | $22.63 | 496.9M | $11.24B | $545M | $4.02B | $14.72B |
| 2025-09-30 | $20.14 | 496.8M | $10.01B | $505M | $4.02B | $13.52B |
| 2025-06-30 | $14.28 | 496.6M | $7.09B | $539M | $4.21B | $10.76B |
| 2025-03-31 | $10.50 | 495.1M | $5.2B | $487M | $4.4B | $9.11B |
| 2024-12-31 | $12.11 | 494.4M | $5.99B | $468M | $4.32B | $9.84B |
| 2024-09-30 | $14.69 | 494.3M | $7.26B | $490M | $4.36B | $11.13B |
| 2024-06-30 | $14.10 | 494.2M | $6.97B | $416M | $5.68B | $12.23B |
| 2024-03-31 | $15.97 | 493.2M | $7.88B | $345M | $5.76B | $13.3B |
| 2023-12-31 | $14.90 | 492.8M | $7.34B | $352M | $5.77B | $12.76B |
| 2023-09-30 | $11.24 | 492.7M | $5.54B | $369M | $5.91B | $11.08B |
| 2023-06-30 | $10.06 | 492.6M | $4.96B | $367M | $6.06B | $10.65B |